Verastem Financial Statements From 2010 to 2021

VSTM -  USA Stock  

USD 2.76  0.01  0.36%

Verastem financial statements provide useful quarterly and yearly information to potential Verastem investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Verastem financial statements helps investors assess Verastem's valuation, profitability, and current liquidity needs.
There are over sixty-seven available fundamental trend indicators for Verastem, which can be analyzed over time and compared to other ratios. Please make sure you double-check all of Verastem current fundamentals over time between 2010 and 2021 to make sure the company is sustainable down the road.
Verastem Enterprise Value is relatively stable at the moment as compared to the past year. The company's current Enterprise Value is estimated at 57.44 Million. Market Capitalization is expected to hike to about 81.1 M this year, although the value of Net Income Per Employee will most likely fall to (1.5 M).

Verastem Financial Statements 

 
Refresh
Check Verastem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Verastem main balance sheet or income statement drivers, such as Direct Expenses of 36.4 M, Operating Expenses of 43.9 M or Preferred Dividends Income Statement Impact of 7.1 K, as well as many exotic indicators such as Long Term Debt to Equity of 0.17, PPandE Turnover of 140 or Receivables Turnover of 68.94. Verastem financial statements analysis is a perfect complement when working with Verastem Valuation or Volatility modules. It can also supplement various Verastem Technical models. Also, please take a look at the analysis of Verastem Correlation against competitors.

Verastem Revenues

95.5 MillionShare

Verastem Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets128.8 M154.3 M114.3 M
Increasing
Slightly volatile
Cash and Equivalents53.6 M67.8 M43.5 M
Increasing
Slightly volatile
Investments99.5 M98.2 M88 M
Increasing
Stable
Investments Current69.2 M76.8 M74.1 M
Increasing
Slightly volatile
Investments Non Current30.1 M25.7 M25.4 M
Decreasing
Slightly volatile
Property Plant and Equipment Net1.6 M1.8 M1.6 M
Increasing
Slightly volatile
Trade and Non Trade PayablesM3.5 M3.2 M
Increasing
Slightly volatile
Total Liabilities36.2 M39.1 M37 M
Increasing
Slightly volatile
Shareholders Equity92.6 M115.3 M77.3 M
Increasing
Stable
Accumulated Other Comprehensive Income31.3 K38.7 K33 K
Increasing
Slightly volatile
Current Assets117.2 M144.9 M98.8 M
Increasing
Slightly volatile
Assets Non Current2.7 M2.6 M8.6 M
Decreasing
Slightly volatile
Current Liabilities14.6 M17.1 M13.3 M
Increasing
Slightly volatile
Liabilities Non Current609 K593.4 K4.4 M
Decreasing
Slightly volatile
Shareholders Equity USD81.5 M92.2 M91 M
Increasing
Slightly volatile
Cash and Equivalents USD30.2 M28.8 M25.7 M
Increasing
Stable
Accounts Payable2.9 M1.9 M4.4 M
Increasing
Slightly volatile
Receivables245.3 K239 K577.7 K
Increasing
Stable
InventoriesM2.8 M986 K
Increasing
Slightly volatile

Verastem Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues95.5 M88.5 M36.8 M
Increasing
Slightly volatile
Selling General and Administrative Expense13.8 M15.9 M15 M
Increasing
Slightly volatile
Research and Development Expense30.1 M36.5 M32 M
Increasing
Slightly volatile
Operating Expenses43.9 M52.4 M47 M
Increasing
Slightly volatile
Preferred Dividends Income Statement Impact7.1 K6.9 K7.3 K
Decreasing
Slightly volatile
Weighted Average Shares165.4 M153.3 M53.3 M
Increasing
Slightly volatile
Weighted Average Shares Diluted165.4 M153.3 M53.7 M
Increasing
Slightly volatile
Direct Expenses36.4 M33.7 M6.2 M
Increasing
Slightly volatile

Verastem Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Investment Acquisitions and Disposals(24.8 M)(24.2 M)(22.9 M)
Increasing
Very volatile
Net Cash Flow from Financing61.5 M69.6 M59.1 M
Increasing
Stable
Issuance Purchase of Equity Shares46.4 M57.6 M50.9 M
Increasing
Slightly volatile
Net Cash Flow from Investing(48.6 M)(47.4 M)(12.8 M)
Decreasing
Very volatile
Net Cash Flow or Change in Cash and Cash Equivalents(10.7 M)(10.4 M)(253.2 K)
Decreasing
Slightly volatile
Share Based Compensation8.2 M9.1 MM
Increasing
Slightly volatile
Depreciation Amortization and Accretion732.2 K678.6 K527.5 K
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Gross Margin79.8861.876993.3434
Decreasing
Slightly volatile
Asset Turnover0.640.58970.2183
Increasing
Slightly volatile
Sales per Share0.480.57570.4157
Increasing
Stable
Price to Book Value0.790.771.3576
Decreasing
Slightly volatile
Debt to Equity Ratio0.170.16531.4839
Increasing
Stable
Current Ratio10.468.479410.3601
Decreasing
Slightly volatile
Book Value per Share2.132.52.4988
Increasing
Stable
Tangible Assets Book Value per Share3.613.525.9819
Decreasing
Slightly volatile
Total Assets Per Share0.930.90555.754
Decreasing
Slightly volatile
Receivables Turnover68.9463.897321.3502
Increasing
Slightly volatile
Inventory Turnover0.650.650.7109
Decreasing
Slightly volatile
PPandE Turnover14013041.6685
Increasing
Slightly volatile
Cash and Equivalents Turnover1.711.58630.4808
Increasing
Slightly volatile
Accounts Payable Turnover16.5215.31214.8607
Increasing
Slightly volatile
Accrued Expenses Turnover5.65.18882.3505
Increasing
Slightly volatile
Long Term Debt to Equity0.170.16531.48
Increasing
Stable
Quick Ratio10.168.276210.2671
Decreasing
Slightly volatile
Net Current Assets as percentage of Total Assets87.6682.828577.0844
Decreasing
Very volatile
Revenue to Assets0.620.57350.1816
Increasing
Slightly volatile

Verastem Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Capitalization81.1 M79 M138.6 M
Decreasing
Slightly volatile
Enterprise Value57.4 M56 M116.6 M
Decreasing
Slightly volatile
Invested Capital63 M61.8 M72.2 M
Decreasing
Slightly volatile
Average Equity99.5 M106.2 M107.6 M
Increasing
Slightly volatile
Average Assets107.4 M115.8 M115.6 M
Increasing
Slightly volatile
Invested Capital Average77.5 M81.8 M84.5 M
Increasing
Stable
Tangible Asset Value93.3 M101.8 M103.8 M
Increasing
Stable
Working Capital79.3 M90.7 M86.8 M
Increasing
Slightly volatile
Revenue Per EmployeeM1.8 M448 K
Increasing
Slightly volatile

Verastem Fundamental Market Drivers

Short Percent Of Float4.23%
Forward Price Earnings-7.46
Shares Short Prior Month13.38M
Average Daily Volume Last 10 Day1.29M
Average Daily Volume In Three Month2.24M
Date Short Interest30th of July 2021
Fifty Day Average2.8160
Two Hundred Day Average3.2149

Verastem Upcoming Events

Upcoming Quarterly Report8th of November 2021
Next Earnings Report17th of March 2022
Next Fiscal Quarter End30th of September 2021
Next Fiscal Year End17th of March 2022
Last Quarter Report30th of June 2021
Last Earning Announcement30th of September 2020

About Verastem Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Verastem income statement, its balance sheet, and the statement of cash flows. Verastem investors use historical funamental indicators, such as Verastem's revenue or net income, to determine how well the company is positioned to perform in the future. Although Verastem investors may use each financial statement separately, they are all related. The changes in Verastem's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Verastem's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Verastem Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Verastem. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Revenues88.5 M95.5 M
Revenue to Assets 0.57  0.62 
Revenue Per Employee1.8 MM
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts. Verastem operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people.

Verastem Investors Sentiment

The influence of Verastem's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Verastem. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - VSTM

Verastem Investor Sentiment

Most of Macroaxis users are at this time bullish on Verastem. What is your outlook on investing in Verastem? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity..
Also, please take a look at the analysis of Verastem Correlation against competitors. Note that the Verastem information on this page should be used as a complementary analysis to other Verastem's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Verastem Stock analysis

When running Verastem price analysis, check to measure Verastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verastem is operating at the current time. Most of Verastem's value examination focuses on studying past and present price action to predict the probability of Verastem's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Verastem's price. Additionally, you may evaluate how the addition of Verastem to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine Verastem value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.